(Press-News.org) CHAPEL HILL, N.C. – A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss.
"This study may be the best result ever for patients whose diabetes is inadequately controlled on a combination of pills and insulin," said John Buse, MD, PhD, lead author of the study and chief of the Division of Endocrinology and Metabolism in the University of North Carolina at Chapel Hill School of Medicine.
"Until now, it was inconceivable that you could get such patients under excellent control with weight loss and no significant problems with hypoglycemia," Buse said.
Type 2 diabetes is a devastating disease, a leading contributor to blindness, amputations, kidney failure, heart attack, stroke and even cancer. But the most powerful diabetes drug, a formulation of insulin called Lantus, is associated with weight gain and low blood sugar reactions that may limit the success of more intensive treatment.
Exenatide (brand name: Byetta) is a newer diabetes drug whose active ingredient was first discovered in the saliva of the Gila monster, a large lizard from the Arizona desert. "It has the advantages of not leading to low blood sugar and in fact promotes weight loss," Buse said.
"Because Byetta and Lantus have very different strengths, we thought that combining the two had the potential to give us the best of both. It is wonderful, when you guess right."
INFORMATION:
The study was published online on Dec. 7, 2010 by the Annals of Internal Medicine and will appear in the Jan. 18, 2011 print issue of the journal.
The 30-week study was conducted at 59 centers in five countries (Greece, Israel, Mexico, the U.K. and the U.S.) with 261 participants. All were adults with type 2 diabetes who were taking once-daily injections of Lantus, either alone or with diabetes pills. They were randomly assigned to receive twice-daily injections of Byetta or placebo in addition to the diabetes medications that they were taking.
Among the 138 patients on Byetta, 60 percent achieved near normal blood sugar levels, compared to 35 percent of those on placebo. Byetta recipients also lost an average of four pounds during the study while placebo recipients gained an average of two pounds. There were no differences in the rates of hypoglycemia between the two groups.
Byetta recipients reported side effects more frequently than placebo recipients, particularly nausea, vomiting and diarrhea, but only in 10 percent of cases were the side effects bad enough to cause patients to stop the drug.
The study was funded and sponsored by an alliance of Eli Lilly and Company and Amylin Pharmaceuticals, who are collaborating to market Byetta.
In addition to Buse, authors of the study are Richard M. Bergenstal, MD; Leonard C. Glass, MD; Cory R. Heilmann, PhD; Michelle S. Lewis, PhD; Anita Y.M. Kwan, MS; Byron J. Hoogwerf, MD; and Julio Rosenstock, MD.
UNC expert: Combining exenatide with insulin may be 'best result ever' for diabetes patients
2010-12-07
ELSE PRESS RELEASES FROM THIS DATE:
Personalized vaccine for lymphoma patients extends disease-free survival by nearly 2 years
2010-12-07
(ORLANDO, Fla.) – A personalized vaccine is a powerful therapy to prevent recurrence among certain follicular lymphoma patients, according to the latest results of ongoing research led by the University of Pennsylvania School of Medicine. The new findings show that when these patients – whose tumors are marked by a specific protein that may be present in up to half of people with this type of cancer -- receive a vaccine made from their own tumor cells, disease-free survival is improved by nearly two years, compared with patients who receive a placebo. Based on the new analysis, ...
Learning the language of bacteria
2010-12-07
MADISON — Bacteria are among the simplest organisms in nature, but many of them can still talk to each other, using a chemical "language" that is critical to the process of infection. Sending and receiving chemical signals allows bacteria to mind their own business when they are scarce and vulnerable, and then mount an attack after they become numerous enough to overwhelm the host's immune system.
This system, called "quorum sensing," is an interesting example of sophistication among microbes, says Helen Blackwell, an associate professor of chemistry at the University ...
Mammogram sensitivity depends on menstrual cycle
2010-12-07
SEATTLE—Try to schedule your screening mammogram during the first week of your menstrual cycle. It might make breast cancer screening more accurate for pre-menopausal women who choose to have regular mammograms. This recommendation comes from an article published online December 3 in Radiology by Diana Miglioretti, PhD, a senior investigator at Group Health Research Institute.
Dr. Miglioretti and her co-authors are working on an issue at the heart of recent controversies about breast cancer screening mammograms. In November 2009, new recommendations—including that women ...
Metabolism models may explain why Alzheimer's disease kills some neuron types first
2010-12-07
Bioengineers from the University of California, San Diego developed an explanation for why some types of neurons die sooner than others in the brains of people with Alzheimer's disease. These insights, published in the journal Nature Biotechnology on November 21, come from detailed models of brain energy metabolism developed in the Department of Bioengineering at the UC San Diego Jacobs School of Engineering.
The Alzheimer's insights demonstrate how fundamental insights on human metabolism can be gleaned from computer models that incorporate large genomic and proteomic ...
Fewer guessing games for lung cancer patients
2010-12-07
Reston, Va. — A study published in the December issue of The Journal of Nuclear Medicine identified positron emission tomography/computed tomography (PET/CT) scans as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA). RFA, which uses localized thermal energy to kill cancer cells, is increasingly used as an alternative treatment for patients unable to undergo surgery or other therapies to treat lung cancer.
"This study reinforces the utility of 18F-FDG-PET imaging in cancer detection and follow-up ...
Imitating someone's accent makes it easier to understand them
2010-12-07
In conversation, we often imitate each other's speech style and may even change our accent to fit that of the person we're talking to. A recent study in Psychological Science, a journal of the Association for Psychological Science, suggests that imitating someone who speaks with a regional or foreign accent may actually help you understand them better.
"If people are talking to each other, they tend to sort of move their speech toward each other," says Patti Adank, of the University of Manchester, who cowrote the study with Peter Hagoort and Harold Bekkering from Radboud ...
Missouri grapes hold key to improving world grape production
2010-12-07
In a few years, a sip of Cabernet Sauvignon, Merlot or Pinot Noir may include a taste of the "Show-Me" State. The state grape of Missouri – the Norton variety grown at many vineyards around the state – is resistant to powdery mildew, a fungal pathogen that affects winemaking grapes around the world. Now, researchers at the University of Missouri are working to identify valuable genes from the Norton grape for eventual transfer into other grapes to make them less susceptible to mildew, decrease fungicide use and increase world-wide grape production.
Walter Gassmann, ...
Early physical therapy for low back pain associated with less subsequent health care utilization
2010-12-07
The American Physical Therapy Association (APTA) is pointing to a new study on low back pain in Medicare patients in its efforts to encourage the newly established Center for Medicare and Medicaid Innovation to promptly launch a demonstration project on direct access to physical therapist services that was recommended in the recent health reform law. The study, published in the journal Spine, showed Medicare patients who received physical therapy in the acute phase following an episode of low back pain were less likely to receive epidural steroid injections, lumbar surgery, ...
Illinois study: Ginseng just got better -- not as bitter
2010-12-07
URBANA – University of Illinois scientists have learned to mask the bitterness of ginseng, a common ingredient of energy drinks.
"Consumers like to see ginseng on a product's ingredient list because studies show that it improves memory, enhances libido and sexual performance, boosts immunity, and alleviates diabetes. But the very compounds that make ginseng good for you also make it taste bitter," said Soo-Yeun Lee, a U of I associate professor of food science and human nutrition.
In an earlier study, Lee and U of I professor of food chemistry Shelly J. Schmidt found ...
Optics Express focus issue on chalcogenide photonics: Fabrication, devices and applications
2010-12-07
WASHINGTON, Dec. 6—Recent progress in chalcogenide glass photonics has been driven by scientific and technological challenges in a variety of areas. These range from increased demand for bandwidth in optical communications, to the emergence of bio-health hazards associated with hazardous microorganisms that absorb at mid-infrared wavelengths, to defense applications that require bright mid-infrared sources. Additionally, chalcogenide glass provides a platform for fundamental investigations of light-matter interactions in nanophotonic structures, such as photonic crystals ...